By setting the survival state as recurrence free survival (RFS) and selecting patients with low mutation burden, we found that higher expression of KHSRP was associated with worse prognosis result (Fig. 1E), indicating that KHSRP expression may be associated with therapeutic efficacy of breast cancer patients. The gene discussed is KHSRP; the disease is breast carcinoma.